Top

Published in:

01-04-2011 | Educational Review

Management of toxic ingestions with the use of renal replacement therapy

Authors: Timothy E. Bunchman, Maria E. Ferris

Published in: Pediatric Nephrology | Issue 4/2011

Abstract

Although rare, renal replacement therapy (RRT) for the treatment of the metabolic, respiratory and hemodynamic complications of intoxications may be required. Understanding the natural clearance of the medications along with their volume of distribution, protein binding and molecular weight will help in understanding the benefit of commencing RRT. This information will aid in choosing the optimal forms of RRT in an urgent setting. Overdose of common pediatric medications are discussed with suggestions on the type of RRT within this educational review.

Borkan SC (2002) Extracorporeal therapies for acute intoxications. Crit Care Clin 18:393–420CrossRefPubMed

Watson WA, Litovitz TL, Rodgers GC (2005) 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23:589–666CrossRefPubMed

Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS (2008) Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 74:1327–1334CrossRefPubMed

dePont AC (2007) Extracorporeal treatment of intoxications. Curr Opin Crit Care 13:668–673CrossRef

Tyagi PK, Winchester JF, Feinfeld DA (2008) Extracorporeal removal of toxins. Kidney Int 74:1231–1233CrossRefPubMed

Zimmerman JL (2003) Poisonings and overdoses in the intensive care unit: General and specific management issues. Crit Care Med 31:2794–2801CrossRefPubMed

Perry HE, Shannon MW (1998) Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 132:5–8CrossRef

Brent J, McMartin K, Phillips S, Burkhart KK, Donovan JW, Wells M, Kulig K (1999) Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. N Engl J Med 18:832–838CrossRef

Lubis HR, Lubis ARR, Hariman H, Parwis B (2008) Extracorporeal methods in the treatment of poisoning. Acta Med Indones 40:84–88PubMed

10.

Brophy PD, Tenebein M, Gardner JJ, Bunchman TE, Smoyer WE (2000) Childhood diethylene glycol poisoning treated with alcohol dehydrogenase inhibitor fomepizole and hemodialysis. Am J Kidney Dis 35:958–962CrossRefPubMed

11.

Goodman JW, Goldfarb DS (2006) The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial 19:402–407CrossRefPubMed

12.

Kim Z, Goldfarb DS (2010) Continuous renal replacement therapy does not have a clear role in the treatment of poisoning. Nephron Clin Pract 115:c1–c6CrossRefPubMed

13.

Berkovitch M, Akilesh MR, Gerace R, Verjee Z, McGuigan M, Whyte H, Koren G (1994) Acute digoxin overdose in a newborn with renal failure: use of digoxin immune Fab and peritoneal dialysis. Ther Drug Monit 16:531–533CrossRefPubMed

14.

Gotch FA, Sargent JA, Keen ML (2000) Whither goest Kt/V? Kidney Int Suppl 76:S3–S18CrossRefPubMed

15.

Okusa MD, Crystal LJ (1994) Clinical manifestations and management of acute lithium intoxication. Am J Med 97:383–389CrossRefPubMed

16.

Amano I, Inagaki Y (1991) Complications and side effects of hemoperfusion. Nippon Rinsho 49(Suppl):649–654PubMed

17.

Spiegel DM, Baker PL, Babcock S, Contiguglia R, Klein M (1995) Hemodialysis urea rebound: the effect of increasing dialysis efficiency. Am J Kidney Dis 25:26–29CrossRefPubMed

18.

Goldstein SL, Somers MJ, Brophy PD, Bunchman TE, Baum M, Blowey D, Mahan JD, Flores FX, Fortenberry JD, Chua A, Alexander SR, Hackbarth R, Symons JM (2004) The prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: design, development and data assessed. Int J Artif Organs 27:9–14PubMed

19.

Messer J, Mulcahy B, Fissell WH (2009) Middle molecule clearance in CRRT: in vitro convection, diffusion and dialyzer area. ASAIO J 55:224–226CrossRefPubMed

20.

Kortgen A, Rauchfuss F, Gotz M, Settmacher U, Bauer M, Sponholz C (2009) Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis—a retrospective analysis. Ther Apher Dial 13:419–425CrossRefPubMed

21.

Karvellas CJ, Bagshar SM, Mcdermid RC, Stollery DE, Gibney RT (2008) Acetaminophen induced acute liver failure treated with single pass albumin dialysis; Report of a case. Int J Artif Organs 31:450–455PubMed

22.

Kramer L, Bauer E, Schenk P, Steininger R, Vigl M, Mallek R (2003) Successful treatment of refractory cerebral oedema in ecstasy/cocaine induced fulminant hepatic failure using a new high efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr 115:599–603CrossRefPubMed

23.

Covic A, Goldsmith DJA, Gusbeth-Tatmoir P, Volvat C, Dimitriu AG, Cristogel F, Bizo A (2003) Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 23(Suppl 3):21–27CrossRefPubMed

24.

Daubin C, Lehoux P, Ivascau C, Tasle M, Bousta M, Lepage O, Quentin C, Massetti M, Charbonneau P (2009) Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Crit Care 13:187–173CrossRef

25.

Lemaire M, Connolly B, Harvey E, Licht C (2010) Treatment of paediatric vancomycin intoxication: a case report and review of the literature. Nephrol Dial Transplant 3:260–264

26.

Bunchman TE, Valentini RP, Gardner JJ, Mottes T, Kudelka T, Maxvold NJ (1999) Treatment of vancomycin overdose using high-efficiency dialysis membranes. Pediatr Nephrol 13:773–776CrossRefPubMed

27.

Schurman SJ, Keeler V, Welch TR (2009) Massive gentamicin overdose in a 14-month-old. Pediatr Nephrol 24:211–213CrossRefPubMed

28.

Eyer F, Pfab R, Felgenhauer N, Lutz J, Heemann U, Steimer W, Zondler S, Fichtl B, Zilker T (2006) Lithium poisoning: Pharmacokinetics and clearance during different therapeutic measures. J Clin Psychopharm 26:325–330CrossRef

29.

van Bommel EFH, Kalmeijer MD, Ponssen HH (2000) Treatment of life threatening lithium toxicity with high volume continuous venovenous hemofiltration. Am J Nephrol 20:408–411CrossRefPubMed

30.

Meyer RJ, Flynn JT, Brophy PD, Smoyer WE, Kershaw DB, Custer JR, Bunchman TE (2001) Hemodialysis followed by continuous hemofiltration for treatment of lithium intoxication in children. Am J Kidney Dis 37:1044–1047CrossRefPubMed

31.

Krause DS, Wolf BA, Shaw LM (1992) Acute aspirin overdose: mechanisms of toxicity. Ther Drug Monit 14:441–451CrossRefPubMed

32.

Higgins RM, Connolly JO, Hendry BM (1998) Alkalinization and hemodialysis in severe salicylate poisoning: comparison of elimination techniques in the same patient. Clin Nephrol 50:178–183PubMed

33.

Shannon MW (1997) Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Acad Emerg Med 4:674–678CrossRefPubMed

34.

Cameron RJ, Hungerford P, Dawson AH (2002) Efficacy of charcoal hemoperfusion in massive carbamazepine poisoning. Clin Toxicol 40:507–512CrossRef

35.

Schuerer DJ, Brophy PD, Maxvold NJ, Kudelka T, Bunchman TE (2000) High efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol 38:321–323CrossRefPubMed

36.

Askenazi DJ, Goldstein SL, Chang IF, Elenberg E, Feig DI (2004) Management of severe carbamazepine overdose using albumin enhanced continuous venovenous hemodialysis. Pediatrics 113:406–409CrossRefPubMed

37.

Sztajnkrycer MD (2002) Valproic acid toxicity: Overview and management. Clin Toxicol 40:789–801CrossRef

38.

Thanacoody RHK (2009) Extracorporeal elimination in acute Valproic acid poisoning. Clin Toxicol 47:609–616CrossRef

39.

Dharnidharka VR, Fennell RS, Richard GA (2002) Extracorporeal removal of toxic Valproic acid levels in children. Pediatr Nephrol 17:312–315CrossRefPubMed

40.

Gubensek J, Buturovic-Ponikvar J, Ponikvar R, Cebular B (2008) Hemodiafiltration and high flux hemodialysis significantly reduce serum valproate levels inducing epileptic seizures: case report. Blood Purif 26:379–380CrossRefPubMed

41.

Kay TD, Playford HR, Johnson DW (2003) Hemodialysis versus continuous venovenous Hemodiafiltration in the management of valproate overdose. Clin Nephrol 59:56–58PubMed

42.

Churchwell MD, Pasko DA, Smoyer WE, Mueller BA (2009) Enhanced clearance of highly protein bound drugs by albumin supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant 24:231–238CrossRefPubMed

43.

Salpeter SR, Greyber E, Pasternak GA, Salpeter EE (2010) Risk of fatal and non fatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev CD002967

44.

Finkle SN (2009) Should dialysis be offered in all cases of metformin associated lactic acidosis? Crit Care 13:110CrossRefPubMed

45.

Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11:694–703CrossRefPubMed

46.

Vilay AM, Mueller BA, Haines H, Alten JA, Askenazi DJ (2010) Treatment of Methotrexate intoxication with various modalities of continuous extracorporeal therapy and glucarpidase. Pharmacotherapy 30:111CrossRefPubMed

47.

Murashima M, Adamski J, Milone MC, Shaw L, Tsai DE, Bloom RD (2009) Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report. Am J Kidney Dis 53:871–874CrossRefPubMed

48.

Bunchman TE, Winters BGM, JW GJJ, Crumb TL, McBryde KD (2007) Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration. Pediatr Nephrol 22:1062–1065CrossRefPubMed

Title: Management of toxic ingestions with the use of renal replacement therapy
Authors: Timothy E. Bunchman
Maria E. Ferris
Publication date: 01-04-2011
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 4/2011
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-010-1654-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Management of toxic ingestions with the use of renal replacement therapy

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

Adverse consequences of accelerated neonatal growth: cardiovascular and renal issues

Relevance of a database for monitoring a cooperative paediatric nephrology project in Nicaragua

Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy

Abdominal pain in a female adolescent: question

Clinical and laboratory features of Macedonian children with OCRL mutations